Adjust Text Size:change font sizechange font sizechange font sizechange font sizechange font sizechange font size

Parkinson's HelpLine


Learn More

Educational Materials


Do you want to know more about Parkinson's? PDF's materials provide information about symptoms, medications, resources & more.

Order Free Materials Today

Science News

Schwarz Pharma’s NDA for Rotigotine Transdermal System is filed by FDA

Schwarz Pharma announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for rotigotine transdermal system on March 29, 2005. The European Medical Agency, EMEA, had already accepted the submission in October 2004. Rotigotine has been formulated as a transdermal delivery system, a patch.

Source Date: Apr 01 2005
Source Publication: Schwarz Pharma
View source URL